IBDEI14D ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18693,1,3,0)
 ;;=3^Bladder Disorders,Other Spec
 ;;^UTILITY(U,$J,358.3,18693,1,4,0)
 ;;=4^N32.89
 ;;^UTILITY(U,$J,358.3,18693,2)
 ;;=^87989
 ;;^UTILITY(U,$J,358.3,18694,0)
 ;;=N33.^^94^912^4
 ;;^UTILITY(U,$J,358.3,18694,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18694,1,3,0)
 ;;=3^Bladder Disorders,Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,18694,1,4,0)
 ;;=4^N33.
 ;;^UTILITY(U,$J,358.3,18694,2)
 ;;=^5015654
 ;;^UTILITY(U,$J,358.3,18695,0)
 ;;=N34.2^^94^912^99
 ;;^UTILITY(U,$J,358.3,18695,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18695,1,3,0)
 ;;=3^Urethritis
 ;;^UTILITY(U,$J,358.3,18695,1,4,0)
 ;;=4^N34.2
 ;;^UTILITY(U,$J,358.3,18695,2)
 ;;=^88231
 ;;^UTILITY(U,$J,358.3,18696,0)
 ;;=N34.1^^94^912^100
 ;;^UTILITY(U,$J,358.3,18696,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18696,1,3,0)
 ;;=3^Urethritis,Nonspec
 ;;^UTILITY(U,$J,358.3,18696,1,4,0)
 ;;=4^N34.1
 ;;^UTILITY(U,$J,358.3,18696,2)
 ;;=^5015655
 ;;^UTILITY(U,$J,358.3,18697,0)
 ;;=N39.0^^94^912^104
 ;;^UTILITY(U,$J,358.3,18697,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18697,1,3,0)
 ;;=3^Urinary Tract Infection,Site Not Spec
 ;;^UTILITY(U,$J,358.3,18697,1,4,0)
 ;;=4^N39.0
 ;;^UTILITY(U,$J,358.3,18697,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,18698,0)
 ;;=N31.0^^94^912^72
 ;;^UTILITY(U,$J,358.3,18698,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18698,1,3,0)
 ;;=3^Neuropathic Bladder,Uninhibited NEC
 ;;^UTILITY(U,$J,358.3,18698,1,4,0)
 ;;=4^N31.0
 ;;^UTILITY(U,$J,358.3,18698,2)
 ;;=^5015644
 ;;^UTILITY(U,$J,358.3,18699,0)
 ;;=R31.9^^94^912^54
 ;;^UTILITY(U,$J,358.3,18699,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18699,1,3,0)
 ;;=3^Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,18699,1,4,0)
 ;;=4^R31.9
 ;;^UTILITY(U,$J,358.3,18699,2)
 ;;=^5019328
 ;;^UTILITY(U,$J,358.3,18700,0)
 ;;=R31.0^^94^912^52
 ;;^UTILITY(U,$J,358.3,18700,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18700,1,3,0)
 ;;=3^Hematuria,Gross
 ;;^UTILITY(U,$J,358.3,18700,1,4,0)
 ;;=4^R31.0
 ;;^UTILITY(U,$J,358.3,18700,2)
 ;;=^5019325
 ;;^UTILITY(U,$J,358.3,18701,0)
 ;;=R31.2^^94^912^53
 ;;^UTILITY(U,$J,358.3,18701,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18701,1,3,0)
 ;;=3^Hematuria,Microscopic
 ;;^UTILITY(U,$J,358.3,18701,1,4,0)
 ;;=4^R31.2
 ;;^UTILITY(U,$J,358.3,18701,2)
 ;;=^5019327
 ;;^UTILITY(U,$J,358.3,18702,0)
 ;;=R31.1^^94^912^51
 ;;^UTILITY(U,$J,358.3,18702,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18702,1,3,0)
 ;;=3^Hematuria,Benign Essential Microscopic
 ;;^UTILITY(U,$J,358.3,18702,1,4,0)
 ;;=4^R31.1
 ;;^UTILITY(U,$J,358.3,18702,2)
 ;;=^5019326
 ;;^UTILITY(U,$J,358.3,18703,0)
 ;;=N40.0^^94^912^30
 ;;^UTILITY(U,$J,358.3,18703,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18703,1,3,0)
 ;;=3^Enlarged Prostate w/o Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,18703,1,4,0)
 ;;=4^N40.0
 ;;^UTILITY(U,$J,358.3,18703,2)
 ;;=^5015689
 ;;^UTILITY(U,$J,358.3,18704,0)
 ;;=N40.1^^94^912^29
 ;;^UTILITY(U,$J,358.3,18704,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18704,1,3,0)
 ;;=3^Enlarged Prostate w/ Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,18704,1,4,0)
 ;;=4^N40.1
 ;;^UTILITY(U,$J,358.3,18704,2)
 ;;=^5015690
 ;;^UTILITY(U,$J,358.3,18705,0)
 ;;=N41.0^^94^912^82
 ;;^UTILITY(U,$J,358.3,18705,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18705,1,3,0)
 ;;=3^Prostatitis,Acute
 ;;^UTILITY(U,$J,358.3,18705,1,4,0)
 ;;=4^N41.0
 ;;^UTILITY(U,$J,358.3,18705,2)
 ;;=^259106
 ;;^UTILITY(U,$J,358.3,18706,0)
 ;;=N45.1^^94^912^31
 ;;^UTILITY(U,$J,358.3,18706,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18706,1,3,0)
 ;;=3^Epididymitis
 ;;^UTILITY(U,$J,358.3,18706,1,4,0)
 ;;=4^N45.1
